Consumer Information - Health Canada Reminds Consumers That Some Ayurvedic Medicinal Products Contain High Levels of Heavy Metals - (May 8, 2008)

 

Foreign Product Alert: vpxl No1 Dietary Supplement for Men - (May 5, 2008)

 

Foreign Product Alerts - Health Canada is advising consumers not to use 7 foreign health products due to concerns about possible side-effects – (April 30, 2008)

 

Foreign Product Alert: Xian Zhi Wei II and Tian Li - (April 29, 2008)

 

Consumer Information - Health Canada Warns Consumers Not to Use Vigoureux or Any Unauthorized Products Promoted for Erectile Dysfunction - (April 25, 2008)

 

Foreign Product Alert: Aspire 36 and Aspire Lite – (April 22, 2008)

 

Foreign Product Alert - Tetrasil, Genisil, Aviralex, OXi-MED, Beta-mannan Micronutrient, Qina and SlicPlus - (April 22, 2008)

 

Consumer Information - Health Canada is advising consumers not to use 2 foreign health products due to concerns about possible side-effects - (April 17, 2008)

 

Notice to Hospitals - Important Safety Information on HEPARIN – (March 28, 2008)

 

Consumer Advisory - Health Canada Warns Consumers not to use a Certain Lot of PediaCol Due to Health Risk – (March 25, 2008)

 

B. Braun Recalls Contaminated Heparin Products in Canada – (March 20, 2008)

 

Health Canada Endorsed Important Safety Information for the drug TEGRETOL (carbamazepine) – (March 20, 2008)

 

Consumer Advisory - Health Canada warns consumers not to use Libidus or any unauthorized products promoted for erectile dysfunction – (March 20, 2008)

 

Consumer Advisory - Health Canada Reminds Canadians not to use Ephedra/Ephedrine Products - (March 13, 2008)

 

Health Professional Advisory - Risk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon - (March 13, 2008)

 

Consumer Advisory - Risk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon - (March 13, 2008)

 

Important Safety Information on Icy Hot Heat Therapy Products – (March 11, 2008)

 

Health Professional Advisory - Reports of Hepatic Failure with EXJADE (deferasirox) - (March 10, 2008)

 

Consumer Advisory - Reports of Hepatic Failure with EXJADE (deferasirox) - (March 10, 2008)

 

Consumer Advisory - Health Canada Warns Consumers not to use ADAM or any Unauthorized Erectile Dysfunction Products - (March 10, 2008)

 

Consumer Advisory - Health Canada reminds Canadians to check medical device clocks for Daylight Saving Time change - (March 10, 2008)

 

Consumer Advisory - Review Determines Measles, Mumps and Rubella Vaccine Lots Can be Released for Use – (March 5, 2008)

 

Consumer Advisory - Health Canada Completes Safety Review of Losec (omeprazole) and Nexium (esomeprazole) – (February 27, 2008)

 

Nine Foreign Product Alerts - (February 21, 2008)

 

Consumer Advisory - Health Canada reviewing issue of distant toxin spread potentially associated with Botox and Botox Cosmetic - (February 21, 2008)

 

Consumer Advisory - Fentanyl Transdermal Pain Patches recalled due to health risk - (February 15, 2008)

 

Three Foreign Product Alerts - (January 31, 2008)

 

Unauthorized health product Yeniujyn contains heavy metals - (January 31, 2008)

 

Recall of ULTIVA (remifentanil hydrochloride) 1 mg vials due to potential for overdose - (January 2, 2008)

 

New warnings regarding ALERTEC (modafinil) and serious rash, allergic reactions, and mental problems - (January 2, 2008)

 

The January 2008 issue of the Canadian Adverse Reaction Newsletter (CARN) is now available. - (January 2, 2008)

 

Important Safety Information and availability of Trasylol (aprotinin) – November 27, 2007

 

New restrictions on the use of rosiglitazone products due to cardiac safety concerns (Avandia, Avandamet, Avandaryl) - (November 7, 2007)

 

Urgent Medical Device Information on Medtronic Sprint Fidelis Lead Recall and Patient Management Recommendations - (November 7, 2007)

 

Important Safety Information on Abbott Diabetes Care Precision Xtra – (October 31, 2007)

 

Urgent Medical Device Information on Medtronic Sprint Fidelis Lead Recall and Patient Management Recommendations - (October 29, 2007)

 

Important Safety Information Regarding Colleague Volumetric Infusion Pumps – (October 24, 2007)

 

Important safety information on Definity (Perflutren Injectable Suspension) – October 19, 2007

 

Important Safety Information on Iressa (gefitinib)- (October 11, 2007)

 

Withdrawal of Market Authorization for Prexige (lumiracoxib) - (October 11, 2007)

 

Important Safety Information on Sodium Phosphates Injection - (October 2, 2007)

 

Safety Alert Notification for IV Administration Sets - (September 18, 2007)

 

Safety Information related to VIRACEPT (nelfinavir mesylate) and ethyl methanesulfonate (EMS) - (September 11, 2007)

 

Important Safety Information on KETEK (telithromycin) - (September 5, 2007)

 

Important Safety Information on THELIN (sitaxsentan sodium)- (August 23, 2007)

 

Cease Sale of Permax (pergolide mesylate) in Canada as of August 30, 2007 - (August 16, 2007)

 

Important Safety Information on RITUXAN (rituximab) - (August 14, 2007)

 

Important Product information on the Colleague Volumetric Infusion Pumps - (August 14, 2007)

 

Important Safety Information on Medtronic MiniMed Paradigm Insulin Infusion Pump - (August 14, 2007)

 

Important Safety Information on Xylocaine (Lidocaine HCI) Jelly 2% Single Use Plastic Syringe (10 mL): Update - (August 8, 2007)

 

Urgent: Product Safety and Recall Notification regarding Smiths Medical CADD Medication Cassette Reservoirs - (July 25, 2007)

 

Health Canada Endorsed Important Safety Information on FLUOTIC (sodium fluoride) 20 mg tablets – June 27, 2007

 

Health Canada Endorsed Important Safety Information on Sensipar (cinacalcet hydrochloride) - (June 27, 2007)

 

Important Safety Information on VENTOLIN I.M. injection and VENTOLIN I.V. infusion solution for pregnant women & labour and delivery - (June 15, 2007)

 

Association of AVASTIN (bevacizumab) with tracheo-esophageal (TE) fistula - (June 12, 2007)

 

Health Canada Endorsed Important Safety Information on FRAXIPARINE AND FRAXIPARINE FORTE graduated syringes - (June 8, 2007)

 

Health Canada Issued Safety Information on Bone Cements Used in Vertebroplasty and Kyphoplasty Procedures - (June 4, 2007)

 

Health Canada Endorsed Important Safety Information on Avandia, Avandamet and Avandaryl - (June 4, 2007)

 

URGENT PRODUCT NOTIFICATION - Health Canada Endorsed Important Safety Information on OneTouch Ultra Test Strips - (May 23, 2007)

 

Voluntary Type I Recall of ratio-Valproic (valproic acid) 500-mg Enteric-Coated Capsules in Canada - (May 17, 2007)

 

Information Regarding Myozyme (alglucosidase alfa)- (May 17, 2007)

 

Voluntary Type I Recall of Depakene (valproic acid) 500-mg Enteric-Coated Capsules in Canada - (May 16, 2007)

 

Health Canada Endorsed Important Safety Information on a subset of Implantable Cardiac Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) - (May 10, 2007)

 

Health Canada Endorsed Important Safety Information on ACTOS (pioglitazone hydrochloride) - (May 8, 2007)

 

Important Safety Information and New Prescribing Information for the Erythropoiesis-Stimulating Agents, Aranespฎ (darbepoetin alfa) and EPREX (epoetin alfa) – (April 20, 2007)

 

Health Canada Endorsed Important Safety Information on Defibtech DDU-100 Series Automatic External Defibrillators  - (April 20, 2007)

 

URGENT: Marketing and Sales Suspension Notice for Zelnorm Tablets, 6 mg - (April 2, 2007)

 

Health Canada Endorsed Important Safety Information on Trasylolฎ [aprotinin] - (April 2, 2007)

 

Health Canada Endorsed Important Safety Information on Exjade* (deferasirox) – (March 19, 2007)

 

Health Canada Issued Important Safety Information on Gadolinium-Containing Contrast Agents – (March 13, 2007)

 

Health Canada Endorsed Important Safety Information on ^PrAvandia^ฎ, ^PrAvandamet^ฎ and ^PrAvandaryl^TM - (February 23, 2007)

 

Important Information Regarding BARACLUDE* (entecavir) in Patients Co-infected with HIV and HBV - (February 23, 2007)

 

Health Canada Endorsed Important Safety Information on Fisher & Paykel Healthcare Continuous Positive Airway Pressure ("CPAP") Masks and Connectors – (February 13, 2007)

 

Increased mortality and risk of serious adverse events when prophylactic heparin is abruptly discontinued in patients to be started on Xigris [drotrecogin alfa (activated)] for severe sepsis – (January 2, 2007)

 

Health Canada Endorsed Important Safety Information on Iressa (gefitinib) – (December 12, 2006)

 

Health Canada Endorsed Important Safety Information on Xylocaine (lidocaine HCl) Jelly 2% Single Use Plastic Syringe (10 mL) – (December 6, 2006)

 

Health Canada Issued Important Safety Information on Benzocaine Sprays - (November 24, 2006)

 

New Safety Information about EVRA* (norelgestromin and ethinyl estradiol) Transdermal System - (November 24, 2006)

 

Reports of Bowel Obstruction and Gastrointestinal Perforation with RITUXAN^ฎ (rituximab) – (November 14, 2006)

 

Association of AVASTINฎ (bevacizumab) with hypertensive encephalopathy and reversible posterior leukoencephalopathy syndrome (RPLS) – (October 27, 2006)

 

Association of CellCept (mycophenolate mofetil) and sirolimus containing immunosuppressant regimen with higher rate of acute rejection in cardiac transplant patients switched from calcineurin inhibitors – (October 26, 2006)

 

Association of Syringe Infusion Pumps with a Risk of Delay in Detection of Downstream Occlusion – (October 26, 2006)

 

Health Canada Endorsed Important Safety Information on Ketek (telithromycin) – (October 3, 2006)

 

Health Canada Endorsed Important Safety Information on Gleevac (imatinib mesylate) - (October 2, 2006)

 

Health Canada Endorsed Important Safety Information on the Alaris SE Pump (formerly Signature Edition Infusion Pump) – (September 20, 2006)

 

Health Canada Endorsed Important Safety Information on the recall of the Mallinckrodt Satin-Slip Intubating Stylet - 6 FR - (September 14, 2006)

 

Health Canada Endorsed Important Safety Information on Rapamune (sirolimus) – (August 25, 2006)

 

Drug Identification Number (DIN) cancellation and Recall of Thioridazine in Canada - (August 21, 2006)

 

Health Canada Endorsed Important Safety Information on the Association of LAMICTAL^ฎ (lamotrigine) with an increased risk of non-syndromic oral clefts – (August 8, 2006)

 

Health Canada Endorsed Important Safety Information on Remicade (infliximab) – (July 27, 2006)

 

Health Canada Endorsed Important Safety Information on certain Guidant/Boston Scientific pacemakers and defibrillators – (July 20, 2006)

 

Health Canada Endorsed Important Safety Information on Omniscan (gadodiamide) injection – (July 18, 2006)

 

Health Canada Endorsed Important Safety Information on Aptivus (tipranavir) – (July 6, 2006)

 

Health Canada Endorsed Important Safety Information on Anzemet (dolasetron mesylate): NEW CONTRAINDICATIONS – (July 4, 2006)

 

Health Canada Endorsed Important Safety Information on Cialis (tadalafil), Levitra (vardenafil hydrochloride) and Viagra (sildenafil citrate) – (June 28, 2006)

 

Health Canada Endorsed Important Safety Information on the recall of certain lots of SureStep Blood Glucose Meters – (June 23, 2006)

 

Health Canada released today two documents as part of its ongoing evaluation of COX-2-selective drugs - (June 15, 2006)

 

Health Canada Endorsed Important Safety and Efficacy Information on Iressa (gefitinib) 250 mg Tablets -